Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
IOL Chemicals & Pharmaceuticals
Small Cap•2,777 Employees•IPO 2010
Current Price
₹73.98
3.1 (4.37%)Updated
Today's Range
₹70.54
₹74.80
₹73.98
52 Week Range
52W Low₹57.50
52W High₹355.00
₹73.98
Downside28.66%
Upside379.86%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹2,192.65 Cr
Market Cap
Total market value of companyP/E Ratio
18.95
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
1.72
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹3.95
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
3.57%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
8.87%
ROCE
Return on Capital Employed. >15% is goodNet Margin
5.20%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-44.15%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
1.88%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
9.82%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
13.20%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.07
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹57.50
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
52.60%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •IOLCP exhibits a robust promoter holding of 52.6%, suggesting strong management confidence and reduced risk of hostile takeovers. This high percentage indicates a significant alignment of interests between management and shareholders, potentially leading to long-term value creation.
- •Despite recent stock price volatility, IOLCP shows a relatively low debt-to-equity ratio of 0.07, indicating a healthy financial structure and lower risk of financial distress. This strong balance sheet provides a solid foundation for future growth and investment.
Weaknesses
4 points- •While recent quarterly profits are positive, IOLCP's Return on Equity (ROE) of 6.13% is relatively modest compared to industry benchmarks. Investors should assess whether this return adequately compensates for the inherent risks associated with the pharmaceutical sector.
- •The stock price has experienced significant volatility, with a 52-week high of 457.70 and a low of 57.50. This high degree of price fluctuation presents considerable risk for investors seeking stability and predictable returns.
Opportunities
3 points- •The company operates in the Pharmaceuticals sector, which is poised for growth due to increasing healthcare expenditure, rising chronic disease prevalence, and expanding global demand for generic drugs and APIs.
- •As a chemicals and pharmaceuticals company, IOLCP can capitalize on the global trend towards diversified API sourcing and 'China Plus One' strategies, potentially increasing its market share and export opportunities in key markets.
Threats
4 points- •IOLCP faces intense competition from larger, more established players in the pharmaceutical sector, as evidenced by peers like Sun Pharma and Divi's Lab with significantly higher market caps and ROCE.
- •The pharmaceutical industry is subject to stringent regulatory changes and compliance requirements, which could lead to increased operational costs, delays in product approvals, or potential penalties for IOLCP.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹84.19 | +₹10.21 | +13.81% |
| R3 | ₹79.93 | +₹5.95 | +8.05% |
| R2 | ₹77.37 | +₹3.39 | +4.58% |
| R1 | ₹75.67 | +₹1.69 | +2.29% |
| PIVOT | ₹73.11 | -0.87 | -1.18% |
| CURRENT | ₹73.98 | - | - |
| S1 | ₹62.89 | -₹11.09 | -14.99% |
| S2 | ₹67.15 | -₹6.83 | -9.23% |
| S3 | ₹68.85 | -₹5.13 | -6.94% |
| S4 | ₹71.41 | -₹2.57 | -3.47% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+121.1% vs avg
2.04M
(06 Mar 2026)Delivery %+17.3% vs avg
65.5%
(06 Mar 2026)Avg Volume (20D)20-day average
9.24L
(06 Feb - 06 Mar)Avg Delivery %Trend ↑
48.2%
(06 Feb - 06 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Solara Active Pharma Sciences Ltd
178.00 %
Highest Dividend Yield
RPG Life Sciences Ltd
1.22 %
Peer Comparison
| Company Name |
|---|
 Aarti Drugs Ltd |
 Amrutanjan Health Care Ltd |
 Beta Drugs Ltd |
 Bliss GVS Pharma Ltd |
 Gufic BioSciences Ltd |
 Hikal Ltd |
 Indoco Remedies Ltd |
 Morepen Laboratories Ltd |
 NGL Fine Chem Ltd |
 RPG Life Sciences Ltd |
 Senores Pharmaceuticals Ltd |
 SMS Pharmaceuticals Ltd |
 Solara Active Pharma Sciences Ltd |
 Sun Pharmaceutical Industries Ltd |
 Unichem Laboratories Ltd |
About
IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals and Pharmaceuticals Limited (IOLCP) is a prominent Indian company engaged in the manufacturing and sale of pharmaceutical and chemical products both domestically and globally. Their core business revolves around the production and distribution of a wide range of Active Pharmaceutical Ingredients (APIs).
A significant portion of IOLCP's API portfolio focuses on ingredients used in various therapeutic areas. This includes APIs for anti-inflammatory, analgesic and antipyretic treatments (like ibuprofen lysinate and ibuprofen sodium), anti-diabetic medications (metformin), anti-platelet agents (clopidogrel bisulphate), cholesterol-lowering drugs (fenofibrate), anti-convulsants (lamotrigine, gabapentin, levetiracetam), and proton pump inhibitors (pantoprazole). The company also produces paracetamol, a common analgesic and antipyretic.
Beyond pharmaceuticals, IOLCP demonstrates a strong presence in the specialty industrial chemicals market. They supply a diverse array of products including ethyl acetate, isobutyl benzene, acetyl chloride, para-aminophenol, and monochloroacetic acid. These chemicals find applications across a wide spectrum of industries, such as food processing, flexible packaging, pharmaceuticals, textiles, ink and paint manufacturing, pesticide production, and the creation of chemical intermediates. This diversification allows IOLCP to cater to multiple sectors and reduces reliance on any single market.
Established in 1986 and headquartered in Ludhiana, India, IOLCP has a long history of operation within the chemical and pharmaceutical sectors. Their success is built on the foundation of providing high-quality APIs and specialty chemicals, contributing significantly to various industries both within India and internationally. The company's broad product range and diversified customer base solidify its position as a key player in the market.
COMPANY FACTS - IOLCP
Registered Address
85, Industrial Area, `A',
Ludhiana
PUNJAB
IN
Tel: 911612225531
Website:https://www.iolcp.com/
Investor Relations:https://www.iolcp.com/investors/events
Company Details
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 2,777
IPO Date: 05/11/2010
MANAGEMENT - IOLCP
Mr. Rajender Malla
Independent Non-Executive Chairman of the Board
Mr. Pardeep Khanna
Chief Financial Officer
Mr. Abhay Singh
Vice President, Company Secretary
Mr. Varinder Gupta
Managing Director, Executive Director
Mr. Vikas Gupta
Joint Managing Director, Executive Director
Mr. Abhiraj Gupta
Executive Director
Mr. Kushal Rana
Executive Director, Director - Works
Ms. Rajni Jha
Additional Independent Director
Mr. Harpal Singh
Independent Director
Mr. Sharad Tyagi
Independent Director
Investor Questions Answered
IOL Chemicals & Pharmaceuticals Ltd (IOLCP) Stock FAQs
Get answers to the most common questions about IOL Chemicals & Pharmaceuticals Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of IOL Chemicals & Pharmaceuticals Ltd (IOLCP) is ₹73.98. Today, the stock has gained by ₹3.10 (4.37%), trading in a range of ₹70.54 to ₹74.8. The stock opened at ₹70.88 with a trading volume of 20,42,835 shares.
IOL Chemicals & Pharmaceuticals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,192.65 crores, P/E ratio of 18.95, ROE of 3.57%, and ROCE of 8.87%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of IOL Chemicals & Pharmaceuticals Ltd (IOLCP) is ₹355, while the 52-week low is ₹57.5. Currently trading at ₹73.98, the stock is 5.5% away from its 52-week low and 79.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy IOL Chemicals & Pharmaceuticals Ltd stock at ₹73.98 depends on multiple factors. The stock is currently trading with a P/E ratio of 18.95 and P/B ratio of N/A. Today's performance shows a gain of 4.37%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
IOL Chemicals & Pharmaceuticals Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹73.98, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
IOL Chemicals & Pharmaceuticals Ltd's key financial metrics include: P/E Ratio: 18.95, P/B Ratio: N/A, ROE: 3.57%, ROCE: 8.87%, Dividend Yield: 0.00%, EPS: ₹3.95, Book Value: ₹57.5, Debt-to-Equity: 0.07, and Current Ratio: N/A. The company's market cap stands at ₹2,192.65 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
IOL Chemicals & Pharmaceuticals Ltd stock opened at ₹70.88 and is currently trading at ₹73.98, showing a gain of ₹3.10 (4.37%). The intraday high is ₹74.8 and low is ₹70.54. The trading volume stands at 20,42,835 shares, indicating strong market participation today.
IOL Chemicals & Pharmaceuticals Ltd has a Price-to-Earnings (P/E) ratio of 18.95, which means investors are willing to pay ₹18.95 for every ₹1 of earnings. With an EPS of ₹3.95, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of ₹2,192.65 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹73.98) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
IOL Chemicals & Pharmaceuticals Ltd has a book value of ₹57.5 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹73.98, which is 28.7% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
IOL Chemicals & Pharmaceuticals Ltd has a Return on Equity (ROE) of 3.57% and Return on Capital Employed (ROCE) of 8.87%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
IOL Chemicals & Pharmaceuticals Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
IOL Chemicals & Pharmaceuticals Ltd has a debt-to-equity ratio of 0.07, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
IOL Chemicals & Pharmaceuticals Ltd has an Earnings Per Share (EPS) of ₹3.95, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹73.98 and P/E ratio of 18.95, investors are paying 18.95 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
IOL Chemicals & Pharmaceuticals Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
IOL Chemicals & Pharmaceuticals Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze IOL Chemicals & Pharmaceuticals Ltd stock, consider: 1) Fundamental Analysis - Review P/E (18.95), ROE (3.57%), debt-to-equity (0.07), and growth rates. 2) Technical Analysis - Check 52-week range (₹57.50 - ₹355.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹73.98) with book value (₹57.50) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of IOL Chemicals & Pharmaceuticals Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹73.98 is 3599x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in IOL Chemicals & Pharmaceuticals Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹57.50 - ₹355.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.07 indicates leverage. 4) Liquidity Risk - Based on trading volume of 20,42,835 shares. 5) Valuation Risk - P/E of 18.95 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
IOL Chemicals & Pharmaceuticals Ltd operates in the industry with key metrics: P/E ratio of 18.95, ROE of 3.57%, market cap of ₹2,192.65 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.07), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for IOL Chemicals & Pharmaceuticals Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹73.98, with a 52-week range of ₹57.50 to ₹355.00. Based on fundamentals like P/E (18.95), ROE (3.57%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling IOL Chemicals & Pharmaceuticals Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹73.98. 2) Fundamental Deterioration - Declining ROE (currently 3.57%), increasing debt (D/E: 0.07), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for IOL Chemicals & Pharmaceuticals Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu